Asbestos Diseases Research Institute
- Research works
- 84 ▼ 12% vs 2013–17
- Citations
- 2.9k 34.3 per fractional work
- Top-10% rate
- 23.4% record average 16.5%
- Open access
- 64% world 28%
Not ranked overall: Asbestos Diseases Research Institute is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.5×. Every wedge is a field page.
- Immunology and Microbiology 3.5×
- Environmental Science 2.9×
- Medicine 2.9×
- Biochemistry, Genetics and Molecular Biology 2.4×
- Economics, Econometrics and Finance 1.8×
- Health Professions 1.2×
- Engineering 0.3×
- Neuroscience 0.2×
- Agricultural and Biological Sciences 0.2×
- Materials Science 0.2×
- Psychology 0.2×
- Social Sciences 0.0×
Who are the top researchers at Asbestos Diseases Research Institute?
Ranked on the composite score, Glen Reid and Yuen Yee Cheng lead among researchers whose main affiliation is Asbestos Diseases Research Institute.
- 1 Glen Reid Australia · #84,673 worldwide 271 citations · 39 works
- 2 Yuen Yee Cheng Australia · #1,574,993 worldwide 11 citations · 21 works
Which keywords describe research at Asbestos Diseases Research Institute?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Radiation Therapy, BAP1 mutations, Malignant Pleural Mesothelioma, Cancer, Pneumothorax, Biogenesis and Gene Expression.
- TGF-ß
- Cancer Progression
- Fibrosis
- Pulmonary Sclerosing Hemangioma
- Dendritic Cells
- Antigen Presentation
- Epithelial-Mesenchymal Transition
- Health Effects
- Cancer Immunotherapy
- Innate Immunity
- Immunity
- Immune Checkpoint Blockade
- Targeting
- Tumor Microenvironment
- Regulation
- Gene Expression
- Biomarkers
- Biogenesis
- Malignant Pleural Mesothelioma
- Radiation Therapy
- Immunotherapy
- BAP1 mutations
- Cancer
- Pneumothorax
- Empyema
- Pleural Effusion
- Metastasis
- MicroRNA
- Oxidative Stress
- PD-1 and PD-L1
- Cardiovascular Disease
- Mortality
- Gene Therapy
- Air Pollution
- Particulate Matter
- Chemotherapy
- Pulmonary Alveolar Microlithiasis
- Targeted Therapy
- Tumor Targeting
- Tumor Regression
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy25▲ 46×10 topics
- Radiation Therapy21▲ 173×3 topics
- BAP1 mutations21▲ 1098×1 topic
- Malignant Pleural Mesothelioma21▲ 1098×1 topic
- Cancer7▲ 6.3×18 topics
- Biogenesis6▲ 62×3 topics
- Pneumothorax6▲ 177×2 topics
- Biomarkers6▲ 11×5 topics
- Empyema6▲ 212×1 topic
- Gene Expression6▲ 11×9 topics
- Pleural Effusion6▲ 212×1 topic
- Regulation5▲ 10×5 topics
- Metastasis5▲ 17×6 topics
- Tumor Microenvironment4▲ 15×7 topics
- MicroRNA4▲ 41×1 topic
- Targeting4▲ 71×1 topic
- Oxidative Stress3▲ 2.2×11 topics
- Immune Checkpoint Blockade3▲ 70×1 topic
- PD-1 and PD-L13▲ 70×1 topic
- Immunity3▲ 10×3 topics
- Cardiovascular Disease3▲ 3.0×6 topics
- Innate Immunity3▲ 9.2×3 topics
- Mortality3▲ 6.5×4 topics
- Cancer Immunotherapy3▲ 22×2 topics
- Gene Therapy3▲ 12×2 topics
- Health Effects3▲ 5.1×3 topics
- Air Pollution2▲ 26×1 topic
- Epithelial-Mesenchymal Transition2▲ 35×2 topics
- Particulate Matter2▲ 26×1 topic
- Antigen Presentation2▲ 28×1 topic
- Chemotherapy2▲ 4.0×6 topics
- Dendritic Cells2▲ 24×1 topic
- Pulmonary Alveolar Microlithiasis2▲ 70×1 topic
- Pulmonary Sclerosing Hemangioma2▲ 70×1 topic
- Targeted Therapy2▲ 12×3 topics
- Fibrosis2▲ 13×4 topics
- Tumor Targeting2▲ 18×3 topics
- Cancer Progression2▲ 10×5 topics
- Tumor Regression2▲ 26×2 topics
- TGF-ß2▲ 12×2 topics
Which research topics does Asbestos Diseases Research Institute publish most on?
By volume in 2022–2025: Occupational and environmental lung diseases, Environmental and Social Impact Assessments, Air Quality and Health Impacts and Pleural and Pulmonary Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Occupational and environmental lung diseases Pulmonary and Respiratory Medicine 4 works
- 2 Environmental and Social Impact Assessments Management, Monitoring, Policy and Law 1 works
- 3 Air Quality and Health Impacts Health, Toxicology and Mutagenesis 1 works
- 4 Pleural and Pulmonary Diseases Pulmonary and Respiratory Medicine 0 works
- 5 Firm Innovation and Growth Economics and Econometrics 0 works
- 6 Cancer Research and Treatments Biotechnology 0 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 8 Extracellular vesicles in disease Molecular Biology 0 works
- 9 Occupational exposure and asthma Public Health, Environmental and Occupational Health 0 works
- 10 Myasthenia Gravis and Thymoma Neurology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Asbestos Diseases Research Institute's research output changed?
Output in 2018–2022 was 12% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.